-
P2P MDA Night of Hope
NSI-566/ALS Phase I patient #12, Edward Tessaro’s, story with ALS is spotlighted on the eve of the 8th Annual MDA-ALS Night of Hope benefit in Atlanta. Site Principal Investigator, Emory’s Dr. Jonathan D. Glass, is also interviewed in this segment which includes surgery footage of the cell therapy treatment using Neuralstem’s proprietary breakthrough medical devices, the Spinal Platform and Floating Cannula.
Select media coverage in this website is provided for the information and convenience of the public, and is not intended to be all-encompassing nor an endorsement of the specific stories or media outlets.